Adjuvant Imatinib in High-Risk GIST: The Longer the BetterAdjuvant Imatinib in High-Risk GIST: The Longer the Better
Patients with localized, high-risk GIST fare better when treated with adjuvant imatinib. Dr. Maurie Markman looks at how longer use of targeted therapy improves outcomes even further. Medscape Genomic Medicine (Source: Medscape Today Headlines)

Folic acid tied to lower child cancer risks
NEW YORK (Reuters Health) - Rates of two rare childhood cancers declined after the U.S. began requiring grain products to be fortified with the B vitamin folic acid, a new study finds. (Source: Reuters: Health)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div